MedTrace Logo

Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough

NCT00743990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2017-11-24

No results posted yet for this study

Summary

This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.

Conditions

  • Respiratory Tract Diseases

Interventions

OTHER

Ointment containing camphor, eucalyptus oil, and menthol

One time use

OTHER

Petroleum jelly

One time use

Sponsors & Collaborators

  • Procter and Gamble

    collaborator INDUSTRY

  • Penn State University

    lead OTHER

Principal Investigators

  • Ian M Paul, MD, MSc · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00743990 on ClinicalTrials.gov